Justice In Aging (Formerly Nsclc)
Highly Engaged Employees
Highly Engaged EmployeesNon-Profit & Charitable Organizations · District of Columbia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1444 Eye St NW Ste 1100, Washington, Dis...Phone Number
(202) 289-6976Website
www.justiceinaging.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Justice In Aging (Formerly Nsclc)
Justice in Aging is a national organization dedicated to combating senior poverty through legal advocacy. They focus on ensuring access to affordable health care, economic security, and legal support for older adults with limited resources. Their services include litigation and advocacy in areas such as housing, health care, and elder rights. The organization aims to improve the lives of millions of older adults who struggle to meet their basic needs.Explore more
Justice In Aging (Formerly Nsclc) Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Justice In Aging (Formerly Nsclc) your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Justice In Aging (Formerly Nsclc) had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Justice In Aging (Formerly Nsclc) has new funding data
Congratulate Masked Content for being promoted to Masked Content at Justice In Aging (Formerly Nsclc)
Justice In Aging (Formerly Nsclc), which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Justice In Aging (Formerly Nsclc) is spiking on competitors!
Earning: See what the market has to say on Justice In Aging (Formerly Nsclc) recently announced quarterly report
Product Launch: Get notified when Justice In Aging (Formerly Nsclc) launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Justice In Aging (Formerly Nsclc) has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Justice In Aging (Formerly Nsclc)
Compare insights from companies similar to Justice In Aging (Formerly Nsclc), focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Justice In Aging (Formerl...
<$5M
11-50
Private
-
1972
TG
Tracey GronnigerManaging Director, Economic Security & Housing
<$5M
1-10
Private
-
2005
LS
Lucille SmithVice Executive Director, Chair, Michuhcan, Voices of Initiative (Detroit)
Company Profile Activity
Activity Insights
Justice In Aging (Formerly Nsclc) is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Justice In Aging (Formerly Nsclc) is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Justice In Aging (Formerly Nsclc).
Justice In Aging (Formerly Nsclc) Tech Stack
A closer look at the technologies used by Justice In Aging (Formerly Nsclc)
Justice In Aging (Formerly Nsclc) News & Media
Alphamab Oncology Presents the updated data from Phase 2 Clinical trial on KN046 Combined with platinum doublet chemotherapy as first-line（1L）treatment for NSCLC at ESMO 2022
2-year survival data of this study were presented: KN046 combined with platinum doublet chemotherapy showed promising efficacy and well tolerated safety as first-line（1L）treatment for advanced NSCLC patients In 87 efficacy evaluable patients, confirmed ORR was 46%. Median OS in non-squamous NSCLC and squamous NSCLC were 27.2 months and 26.6 months respectively. The phase III clinical study of KN046 combined with chemotherapy treatment for sq -NSCLC has met the prespecified PFS endpoint in the fiInnovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium
SUZHOU, China, Aug. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases,...Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced with Eli Lilly and Company ("Lilly", NYSE: LLY) that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug Application (sNDA) for Tyvyt® (sintilimab injection) in combination with ALIMTA®Tyvyt® (Sintilimab Injection) Combined with ALIMTA® (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC
Today, Eli Lilly and Company (NYSE: LLY) jointly announced with Innovent Biologics, Inc. the results of a Phase 3 study in China; the ORIENT-11 trial of Tyvyt® (sintilimab injection) in combination with ALIMTA® (pemetrexed) and platinum in first-line advanced or recurrent nonsquamous non-small cell lung cancer (nsqNSCLC), without sensitive EGFR mutation or ALK rearrangement, met the predefined primary endpoint of progression-free survival (PFS) in an interim analysis.
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Justice In Aging (Formerly Nsclc)
Sign Up For FreeTo access detailed company insights
Justice in Aging is a national organization dedicated to combating senior poverty through legal advocacy. They focus on ensuring access to affordable health care, economic security, and legal support for older adults with limited resources. Their services include litigation and advocacy in areas such as housing, health care, and elder rights. The o... Read More
